293 related articles for article (PubMed ID: 32701602)
21. Immune System and Microvascular Remodeling in Humans.
Rizzoni D; De Ciuceis C; Szczepaniak P; Paradis P; Schiffrin EL; Guzik TJ
Hypertension; 2022 Apr; 79(4):691-705. PubMed ID: 35098718
[TBL] [Abstract][Full Text] [Related]
22. Role of Inflammation and Immunity in Hypertension: Recent Epidemiological, Laboratory, and Clinical Evidence.
Caillon A; Schiffrin EL
Curr Hypertens Rep; 2016 Mar; 18(3):21. PubMed ID: 26846785
[TBL] [Abstract][Full Text] [Related]
23. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
24. Immune mechanisms of salt-sensitive hypertension and renal end-organ damage.
Mattson DL
Nat Rev Nephrol; 2019 May; 15(5):290-300. PubMed ID: 30804523
[TBL] [Abstract][Full Text] [Related]
25. The immune system: role in hypertension.
Schiffrin EL
Can J Cardiol; 2013 May; 29(5):543-8. PubMed ID: 22902155
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-α produced in the kidney contributes to angiotensin II-dependent hypertension.
Zhang J; Patel MB; Griffiths R; Mao A; Song YS; Karlovich NS; Sparks MA; Jin H; Wu M; Lin EE; Crowley SD
Hypertension; 2014 Dec; 64(6):1275-81. PubMed ID: 25185128
[TBL] [Abstract][Full Text] [Related]
27. Innate immunity in hypertension.
Mian MO; Paradis P; Schiffrin EL
Curr Hypertens Rep; 2014 Feb; 16(2):413. PubMed ID: 24407446
[TBL] [Abstract][Full Text] [Related]
28. Immune Mechanisms of Dietary Salt-Induced Hypertension and Kidney Disease: Harry Goldblatt Award for Early Career Investigators 2020.
Elijovich F; Kleyman TR; Laffer CL; Kirabo A
Hypertension; 2021 Aug; 78(2):252-260. PubMed ID: 34232678
[TBL] [Abstract][Full Text] [Related]
29. Is hypertension an immunologic disease?
Harrison DG; Guzik TJ; Goronzy J; Weyand C
Curr Cardiol Rep; 2008 Nov; 10(6):464-9. PubMed ID: 18950555
[TBL] [Abstract][Full Text] [Related]
30. Interleukin 17A: Key Player in the Pathogenesis of Hypertension and a Potential Therapeutic Target.
Davis GK; Fehrenbach DJ; Madhur MS
Curr Hypertens Rep; 2021 Mar; 23(3):13. PubMed ID: 33666761
[TBL] [Abstract][Full Text] [Related]
31. The loss of renal dendritic cells and activation of host adaptive immunity are long-term effects of ischemia/reperfusion injury following syngeneic kidney transplantation.
Ozaki KS; Kimura S; Nalesnik MA; Sico RM; Zhang M; Ueki S; Ross MA; Stolz DB; Murase N
Kidney Int; 2012 May; 81(10):1015-1025. PubMed ID: 22278023
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
[TBL] [Abstract][Full Text] [Related]
33. C-C Motif Chemokine Receptor 7 Exacerbates Hypertension Through Effects on T Lymphocyte Trafficking.
Wen Y; Rudemiller NP; Zhang J; Lu X; Ren J; Privratsky JR; Griffiths R; Zhang JJ; Hammer GE; Crowley SD
Hypertension; 2020 Mar; 75(3):869-876. PubMed ID: 31983306
[TBL] [Abstract][Full Text] [Related]
34. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
Gu Y; Lian Y; Zheng Q; Huang Z; Gu L; Bi Y; Li J; Huang Y; Wu Y; Chen L; Huang Y
BMC Infect Dis; 2020 Jul; 20(1):509. PubMed ID: 32664850
[TBL] [Abstract][Full Text] [Related]
35. Immune mechanisms in hypertension.
Leibowitz A; Schiffrin EL
Curr Hypertens Rep; 2011 Dec; 13(6):465-72. PubMed ID: 21842150
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
[TBL] [Abstract][Full Text] [Related]
37. Adaptive immune disorders in hypertension and heart failure: focusing on T-cell subset activation and clinical implications.
Rai A; Narisawa M; Li P; Piao L; Li Y; Yang G; Cheng XW
J Hypertens; 2020 Oct; 38(10):1878-1889. PubMed ID: 32890260
[TBL] [Abstract][Full Text] [Related]
38. The fungal quorum-sensing molecule farnesol activates innate immune cells but suppresses cellular adaptive immunity.
Leonhardt I; Spielberg S; Weber M; Albrecht-Eckardt D; Bläss M; Claus R; Barz D; Scherlach K; Hertweck C; Löffler J; Hünniger K; Kurzai O
mBio; 2015 Mar; 6(2):e00143. PubMed ID: 25784697
[TBL] [Abstract][Full Text] [Related]
39. [The role of the immune system in the pathogenesis of hypertension].
Leibowitz A; Grossman E
Harefuah; 2014 Jan; 153(1):17-8, 65. PubMed ID: 24605401
[TBL] [Abstract][Full Text] [Related]
40. Immunological insights into hypertension: unraveling triggers and potential therapeutic avenues.
Shokoples BG; Paradis P; Schiffrin EL
Hypertens Res; 2024 May; ():. PubMed ID: 38778172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
